On the Aggregation of Apolipoprotein A-I

被引:5
|
作者
Frankel, Rebecca [1 ,2 ]
Sparr, Emma [2 ]
Linse, Sara [1 ]
机构
[1] Lund Univ, Biochem & Struct Biol, POB 124, SE-22100 Lund, Sweden
[2] Lund Univ, Div Phys Chem, POB 124, SE-22100 Lund, Sweden
基金
瑞典研究理事会; 欧洲研究理事会;
关键词
apolipoprotein A-I; aggregation; condensates; plaques; HIGH-DENSITY-LIPOPROTEINS; CIRCULAR-DICHROISM; ALZHEIMERS-DISEASE; BASIC MECHANISMS; HDL; MYELOPEROXIDASE; NOMENCLATURE;
D O I
10.3390/ijms23158780
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In vivo, apolipoprotein A-I (ApoA-I) is commonly found together with lipids in so-called lipoprotein particles. The protein has also been associated with several diseases-such as atherosclerosis and amyloidosis-where insoluble aggregates containing ApoA-I are deposited in various organs or arteries. The deposited ApoA-I has been found in the form of amyloid fibrils, suggesting that amyloid formation may be involved in the development of these diseases. In the present study we investigated ApoA-I aggregation into amyloid fibrils and other aggregate morphologies. We studied the aggregation of wildtype ApoA-I as well as a disease-associated mutant, ApoA-I K107 Delta, under different solution conditions. The aggregation was followed using thioflavin T fluorescence intensity. For selected samples the aggregates formed were characterized in terms of size, secondary structure content, and morphology using circular dichroism spectroscopy, dynamic light scattering, atomic force microscopy and cryo transmission electron microscopy. We find that ApoA-I may form globular protein-only condensates, in which the alpha-helical conformation of the protein is retained. The protein in its unmodified form appears resistant to amyloid formation; however, the conversion into amyloid fibrils rich in beta-sheet is facilitated by oxidation or mutation. In particular, the K107 Delta mutant shows higher amyloid formation propensity, and the end state appears to be a co-existence of beta-sheet rich amyloid fibrils and alpha-helix-rich condensates.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I
    Mizuguchi, Chiharu
    Nakagawa, Miho
    Namba, Norihiro
    Sakai, Misae
    Kurimitsu, Naoko
    Suzuki, Ayane
    Fujita, Kaho
    Horiuchi, Sayaka
    Baba, Teruhiko
    Ohgita, Takashi
    Nishitsuji, Kazuchika
    Saito, Hiroyuki
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (36) : 13515 - 13524
  • [32] Features of interaction of complexes cortisol-apolipoprotein A-I and tetrahydrocortisol-apolipoprotein A-I with eukariotic DNA
    Panin, LE
    Tuzikov, FV
    Tuzikova, NA
    Polyakov, LM
    [J]. MOLECULAR BIOLOGY, 2006, 40 (02) : 300 - 309
  • [33] Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
    Berthou, L
    Duverger, N
    Emmanuel, F
    Langouet, S
    Auwerx, J
    Guillouzo, A
    Fruchart, JC
    Rubin, E
    Denefle, P
    Staels, B
    Branellec, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11): : 2408 - 2416
  • [34] Characteristics of the interactions of cortisol-apolipoprotein A-I and tetrahydrocortisol-apolipoprotein A-I complexes with eukaryotic DNA
    Panin L.E.
    Tuzikov F.V.
    Tuzikova N.A.
    Polyakov L.M.
    [J]. Molecular Biology, 2006, 40 (2) : 261 - 269
  • [35] Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Van Lenten, BJ
    Datta, G
    Garber, D
    Fogelman, AM
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (06) : 645 - 649
  • [36] RAT APOLIPOPROTEIN A-I (A-I) EPITOPE EXPRESSION IS INFLUENCED BY LIPID ENVIRONMENT
    RICHMOND, JF
    WALSH, MT
    GLASS, C
    ATKINSON, D
    [J]. ARTERIOSCLEROSIS, 1988, 8 (05): : A604 - A605
  • [37] Beneficial Effects of Apolipoprotein A-I on Endotoxemia
    Takashi Imai
    Tetsuji Fujita
    Yoji Yamazaki
    [J]. Surgery Today, 2003, 33 : 684 - 687
  • [38] Apolipoprotein A-I and risk for cardiovascular diseases
    Khuseyinova N.
    Koenig W.
    [J]. Current Atherosclerosis Reports, 2006, 8 (5) : 365 - 373
  • [39] Importance of Apolipoprotein A-I in Multiple Sclerosis
    Gardner, Lidia A.
    Levin, Michael C.
    [J]. FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [40] RADIOIMMUNOASSAY OF APOLIPOPROTEIN A-I OF RAT SERUM
    FAINARU, M
    HAVEL, RJ
    FELKER, TE
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 446 (01) : 56 - 68